Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueReturn on AssetsReturn on Sales

Mainz Biomed (MYNZ) Equity Average (2021 - 2025)

Historic Equity Average for Mainz Biomed (MYNZ) over the last 1 years, with Q4 2021 value amounting to $1.8 million.

  • Mainz Biomed's Equity Average changed N/A to $1.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $4.6 million for FY2024, which is 4640.75% down from last year.
  • Per Mainz Biomed's latest filing, its Equity Average stood at $1.8 million for Q4 2021.
  • Mainz Biomed's 5-year Equity Average high stood at $1.8 million for Q4 2021, and its period low was $1.8 million during Q4 2021.